CA2437387A1 - Method and apparatus for improving mitral valve function - Google Patents

Method and apparatus for improving mitral valve function Download PDF

Info

Publication number
CA2437387A1
CA2437387A1 CA002437387A CA2437387A CA2437387A1 CA 2437387 A1 CA2437387 A1 CA 2437387A1 CA 002437387 A CA002437387 A CA 002437387A CA 2437387 A CA2437387 A CA 2437387A CA 2437387 A1 CA2437387 A1 CA 2437387A1
Authority
CA
Canada
Prior art keywords
coronary sinus
elongated body
straight
substantially rigid
mitral valve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002437387A
Other languages
French (fr)
Inventor
Daniel C. Taylor
John R. Liddicoat
Richard B. Streeter
Steven B. Woolfson
William E. Cohn
Todd F. Davenport
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viacor Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2437387A1 publication Critical patent/CA2437387A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2451—Inserts in the coronary sinus for correcting the valve shape

Abstract

A method and apparatus (100) for reducing mitral regurgitation wherein the apparatus (100) is inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus (100) comprises a guidewire (103), a delivery catheter (106) and a push rod (109) being adapted to straighten the natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation and reduce mitral regurgitation.

Description

METHOD AND APPARATUS FOR
IMPROVING MITRAL VALVE FUNCTION
Reference To Pending Prior Patent Applications This patent application claims benefit of:
(1) pending prior U.S. ProVisional~Patent Application Serial No. 60/266,766, filed 02/05/01 by William E. Cohn et al. for TRANSVASCULAR APPROACH TO
MITRAL VALVE PROCEDURES (Attorney's Docket No. VIA-16 PROV);
(2) pending prior U.S. Provisional Patent Application Serial No. 60/273,893, filed 03/05/01 by William E. Cohn et al. for TRANSVASCULAR METHODS AND
DEVICES FOR MITRAL VALVE PROCEDURES (Attorney's Docket No. VIA-17 PROV);
(3) pending prior U.S. Provisional Patent Application Serial No. 60/278,153, filed 03/23/01 by William E. Cohn et al. for METHOD AND APPPARATUS TO
IMPROVE MITRAL VALVE FUNCTION (Attorney's Docket No.
~0 VIA-18 PROV);
(4) pending prior U.S. Provisional Patent Application Serial No. 60/279,974, filed 03/29/01 by Daniel C. Taylor et al. for METHOD AND APPARATUS TO
IMPROVE MITRAL VALVE FUNCTION (Attorney's Docket No.
VIA-19 PROV);
(5) pending prior U.S. Provisional Patent Application Serial No. 60/280,038, filed 03/30/01 by William E. Cohn et al. for METHODS AND APPARATUS FOR
TEMPORARY IMPROVEMENT IN MITRAL VALVE FUNCTION
20 (Attorney's Docket No. VIA-20 PROV);
(6) pending prior U.S. Provisional Patent Application Serial No. 60/279,973, filed 03/29/01 by Daniel C. Taylor et al. for METHODS AND DEVICES TO
IMPROVE MITRAL VALVE FUNCTION (Attorney's Docket No.
VIA-21 PROV);
(7) pending prior U.S. Provisional Patent Application Serial No. 60/283,820, filed 04/13/01 by William E. Cohn et al. for METHOD AND APPARATUS FOR
TEMPORARY IMPROVEMENT IN MITRAL VALVE FUNCTION
(Attorney's Docket No. VIA-22 PROV);
(8) pending prior U.S. Provisional Patent Application Serial No. 60/312,217, filed 08/14/01 by Daniel C. Taylor et al. for METHOD AND APPARATUS FOR
TEMPORARY IMPROVEMENT IN MITRAL VALVE FUNCTION
(Attorney's Docket No. VIA-23 PROV);
(9) pending prior U.S. Provisional Patent Application Serial No. 60/339,481, filed 10/26/01 by William E. Cohn et al. for TRANSVASCULAR APPROACH TO
MITRAL VALVE PROCEDURES (Attorney's Docket No.
VIA-30 PROV); and (10) pending prior U.S. Provisional Patent Application Serial No. 60/348,424, filed 01/14/02 by Daniel C. Taylor et a~~.. for METHOD AND APPARATUS TO
IMPROVE MITRAL VALVE FUNCTION (Attorney's Docket No.
VIA-31 PROV) .
The aforementioned ten (10) patent applications are hereby incorporated herein by reference.
Field Of The Invention This invention relates to surgical methods and apparatus in general,.~and more particularly to surgical methods and .apparatus for improving mural valve function.
Background Of The Invention Mitral valve repair is the procedure of choice to correct mitral regurgitation of all etiologies. With the use of current surgical techniques, between 70%
and 95% of regurgitant mitral valves can be repaired.
The advantages of mitral valve repair over mitral valve replacement are well documented. These include better preservation of cardiac function and reduced risk of anticoagulant-related hemorrhage, thromboembolism and endocarditis.
In current pxactice, mitral valve surgery requires an extremely invasive approach that includes a chest wall incision, cardiopulmonary bypass, cardiac and pulmonary arrest, and an~incision on the heart itself to gain access to the mitral valve. Such a procedure is associated with high morbidity and mortality. Due to the risk associated with this procedure, many of the sickest patients are denied the potential benefits of surgical correction of mitral regurgitation. In addition, patients with moderate, symptomatic mural regurgitation are denied early intervention and undergo surgical correction only after the development of cardiac dysfunction.
Mitral regurgitation is a common occurrence in patients with heart failure and a source of important morbidity and mortality in these patients. Mitral regurgitation in patients with heart failure is caused by changes in the geometric configurations of the left ventricle, papillary muscles and mural annulus.
These geometric alterations result in incomplete coaptation of the mural leaflets at systole. In this situation, mitral regurgitation is corrected by plicating the mural valve annulus, either by sutures alone or by sutures in combination with a support ring, so as to reduce the circumference of the distended annulus and restore the original geometry of the mitral valve annulus.
More particularly, current surgical practice for mitral valve repair generally requires that the mural valve annulus be reduced in radius by surgically opening the left atrirzm and then fixing sutures, or more commonly sutures in combination with a support ring, to the internal surface of the annulus; this structure is used to cinch the annulus, in a pursestring-like fashion, to a smaller radius, thereby reducing mural regurgitation by improving leaflet coaptation.
This method of mural valve repair, generally termed "annuloplasty", effectively reduces mural regurgitation in hears failure patients. This, in turn, reduces symptoms of heart failure, improves quality of life and increases longetivity.
Unfortunately, however, the invasive nature of mitral valve surgery and the attendant risks render most heart failure patients poor surgical candidates.
Thus, a less invasive means to increase leaflet coaptation and thereby reduce mitral regurgitation in l.
heart failure patient would make this therapy available to a much greater percentage of patients.

Mitral regurgitation also occurs in approximately 200 of patients suffering acute myocardial infarction.
In addition, mitral regurgitation is the primary cause of cardiogenic shock in approximately 10% of patients who develop severe hemodynamic instability in the setting of acute myocardial infarction. Patients with mitral regurgitation and cardiogenic shock have about a 50o hospital mortality. Elimination of mitral regurgitation in these patients would be of significant benefit. Unfortunately, however, patients with acute mitral regurgitation complicating acute myocardial infarction are particularly high-risk surgical candidates, and are therefore not good candidates for a traditional annuloplasty procedure.
Thus, a minimally invasive means to effect a temporary reduction or elimination of mitral regurgitation in these critically ill patients would afford them the time to recover from the myocardial infarction or other acute life-threatening events and make them better candidates for medical, interventional or surgical therapy.

Summary Of The Invention As a result, one object of the present invention is to provide an improved method and apparatus for reducing mitral regurgitation.
Another object of the present invention is to provide a method and apparatus for reducing mitral regurgitation which is minimally invasive.
Another object of the present invention is to provide a method and apparatus for reducing mitral regurgitation which can be deployed either permanently (e.g., for patients s~.~.ffering from heart failure) or temporarily (e. g., for patients suffering from mural regurgitation with acute myocardial infarction).
These and other objects are addressed by the present invention, which comprises an improved method and apparatus for reducing mitral regurgitation.
In one form of the invention, there is provided a method for reducing mi.tral regurgitation comprising:
:, inserting apparav.:us into the coronary sinus of a I,.!
patient in the vicinity of the posterior leaflet of the mitral valve, the.apparatus being adapted to straighten the natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mural regurgitation comprising: .
inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to move at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve anteriorly, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
~0 inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to reduce the degree of natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitr_al valve, whereby to moue the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to increase the natural radius of curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus having a distal end, a proximal end and an intermediate portion, the apparatus being configured so that when the apparatus is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends will apply a posteriorly-directed force to the walls of~the coronary sinus and the intermediate portion Twill apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
inserting a substantially straight elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mural valve, the length of the substantially straight elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adaacent to the posterior leaflet of the mitral valve, whereby.to increase the radius of curvature of the mitral annulus and thereby improve leaflet coaptation. .
In another form of the invention, there is provided a method for reducing mitral regurgitation comprising:
inserting a substantially rigid elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the substantially rigid elongated body being configured relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a different configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided a method for reducing~mitral regurgitation comprising:
inserting a straight, substantially rigid elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the straight, substantially rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mural annulus and thereby improve leaflet coaptation.
In another form of the invention, there is provided an apparatus for reducing mural regurgitation comprising:
a body having a distal end, a proximal end and an intermediate portion,~the body being configured so that when the body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and-proximal ends will apply a posteriorly-directed force to the walls of the coronary sinus, and the intermediate portion will apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus of the mural valve ariteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided an apparatus for reducing mitral regurgitation comprising:
a substantially straight elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length.,of the substantially straight elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus, moving it anteriorly, and thereby improve leaflet Coaptation.
In another form of the invention, there is provided an apparatusjfor reducing mitral regurgitation comprising:
a substantially rigid elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of t=he mitral valve so that when the substantially rigid e_~ongated body is positioned in _ :16 _ the coronary sinus, i~ will cause at least a portion of the coronary sinus-. to assume a different configuration adjacent to the posterior leaflet of the mitral value, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
In another form of the invention, there is provided an apparatus for reducing mitral regurgitation comprising:
a straight, subs~.antially rigid elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mural valve so that ~~hen the straight, substantially rigid elongated body =s positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus, moving it anteriorly, and thereby improve leaflet coaptation.
Significantly, the present invention may be practiced in a minimally invasive manner, either permanently or temporarily, so as to reduce mural regurgitation.
Brief Description Of The Drawings These and other objects and features of the present invention~will be more fully disclosed or rendered obvious by the following detailed description of the preferred embodiments of the invention, which is to be considered together with the accompanying drawings wherein like numbers refer to like parts and further wherein:
Fig. 1 is a schematic view of portions of the human vascular system;
Fig. 2 is a schematic view of portions of the human heart;
Fig. 3 is a schematic view of a preferred system formed in accordance with the present invention;

Figs. 4-7 are a series of views illustrating use of the system of Fig. 3 to reduce mitral regurgitation;
Fig. 8 shows an alternative form of delivery catheter;
Fig. 9 shows an alternative form of flexible push rod;
Fig. 9A shows another alternative form of the present invention;
,:.
Figs. 10 and 11 :~~how alternative constructions for the straight, substantially rigid elongated body;
Fig. 12 shows an alternative system formed in accordance with the present invention; and Fig. 13 shows use of the system shown in Fig. 12.
Detailed Description Of The Preferred Embodiments The coronary sinus is the largest vein in the t.
human heart. During a large portion of its course in the atrioventricular groove, the coronary sinus typically extends adjacent to the left atrium of the heart for a distance of approximately 5 to 10 centimeters. Significantly, for a portion of its length, e.g., typi.cally approximately 7-9 cm, the coronary sinus extends substantially adjacent to the posterior perimeter of the mitral annulus. The present invention takes advantage of this fact. More particularly, by deple~ying.nbvel apparatus in the coronary sinus, adjacent to the posterior leaflet of the mitral valve, the natural curvature of the coronary sinus may be modified in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly so as to improve leaflet coaptation and, as a result, reduce mitral regurgitation.
In one preferred.embodiment of the invention, the novel apparatus compr~_ses a straight, substantially rigid elongated body, the length of the straight, substantially rigid elongated body being sized so that when the straight, substantially rigid body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the straight, substantially rigid elongated body will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leafJ_et of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
And in one preferred embodiment of the invention, access to the coronary sinus is gained percutaneously, e.g., the straight, substantially rigid elongated body is introduced into the patient's vascular system via the jugular vein or. via the left subclavian vein, passed down the super~_or vena cava, passed through the right atrium and then passed into the coronary sinus, where it is deployed. Alternatively, the straight, substantially rigid elongated body may be introduced into the coronary sinus through a small incision in the heart, or through some other incision into the patient's vascular system.
And in one preferred embodiment of the invention, the straight, substantially rigid elongated body is guided into position ~,:~y (i) passing it through a pre-positioned catheter, or (ii) passing it over a pre-positioned guidewire; or (iii) passing it guide-free (e. g., on the end of a steerable delivery tool) to the surgical site.
Once deployed, the novel apparatus may be left in position permanently (e. g., in the case of patients suffering from mitral regurgitation associated with heart failure) or the novel apparatus may be left in position only temporarily (e.g., in the case of patients suffering from mural regurgitation associated with acute myocardial infarction).
Visualization of the procedure may be obtained by fluoroscopy, echocardiography, intravascular ultrasound, angioscopy, real-time magnetic resonance imaging, etc. The efficacy of the procedure may be determined through echocardiography, although other imaging modalities may also be suitable.
Looking now at Fig. 1, there are shown aspects of the cardiovascular system 3 of a patient. More particularly, cardiovascular system 3 generally comprises the heart 6, the superior vena cava 9, the right subclavian vein 12, the left subclavian vein 15, the jugular vein 18, and the inferior vena cava 21.
Superior vena cava 9 and inferior vena cava 21 communicate with the Izeart's right atrium 24. The coronary ostium 27 leads to coronary sinus 30. At the far end 31 (Fig. 2) of coronary sinus 30, the vascular structure turns into the vertically-descending anterior interventricular vein ("AIV") 32 (see Fig. 1). For purposes of the present invention, l0 it can generally be convenient to consider the term "coronary sinus" to mean the vascular structure extending between coronary ostium 27 and AIV 32.
As seen in Fig. 2, between coronary ostium 27 and AIV 32, coronary sinus 30 generally extends substantially adjacent to the posterior perimeter of the annulus 33 of the mitral valve 36. Mitral valve 36 comprises a posterior leaflet 39 and an anterior leaflet 42. In the case of a regurgitant mitral valve, posterior leaflet 39 and anterior leaflet 42 will generally fail to properly coapt at systole, thereby leaving an intervening gap 45 which will permit regurgitation.
Looking next at Fig. 3, there is shown a system 100 which comprises one preferred embodiment of the present invention: More particularly, system 100 generally comprises a guidewire 103, a delivery catheter 106 and a push rod 109.
Guidewire 103 comprises a flexible body 112 having a distal end 115 and a proximal end 118. The distal end 115 of guidewire 103 preferably includes a spring tip 121 for allowing the distal end of guidewire 106 to atraumatically traverse vascular structures, i.e., while the guidewire is being passed through the vascular system of a patient.
Delivery catheter 106 comprises a flexible body 124 having a distal end 127 and a proximal end 130, preferably with an adjustable valve 133 attached. A
central lumen 136 extends from distal end 127 to proximal end 130. In some circumstances it may be desirable to provide a securing mechanism for securing the distal end of the delivery catheter within a vascular structure. By way of example but not limitation, a balloon 139 may be positioned about the exterior of flexible body 124, just proximal to distal end 127, with an inflation lumen l42 extending between balloon 139 and an inflation fitting 145.
Push rod 109 com~arises a flexible body 148 having a distal end 151 and a proximal end 154. A straight, substantially rigid elongated body 157, which may have a variety of different lengths, is formed on flexible body 148, proximal to distal end 151. A removable proximal stiffener or handle 160 may be placed between straight, substantially rigid elongated body 157 and proximal end 154.
System 100 may be used as follows to reduce ,.
mitral regurgitation.
First, distal end 115 of guidewire 103 is passed down the jugular vein 18 (or the left subclavian vein 15) of a patient, down superior vena cava 9, through right atrium 24 of the heart, and then into coronary sinus 30. See Fig. 4. It will be appreciated that as flexible guidewire 103 is passed down coronary sinus 30, the guidewire will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the guidewire. The guidewire's atraumatic springtip 121 will help ensure minimal damage to vascular structures as guidewire 103 is maneuvered into position.
Next, distal end 127 of delivery catheter 106 is placed over proximal end 118 of guidewire 103 and passed down the guidewire until the distal end of the delivery catheter is positioned in coronary sinus 30.
See Fig. 5. Again, ir= will be appreciated that as the flexible delivery catheter 106 passes down the coronary sinus, the delivery catheter will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the delivery catheter.
Once delivery cat,.heter 106 has been positioned within the coronary sinus, guidewire 103 is removed.
See Fig. 6. Either before or after guidewire 103 is ..
removed, balloon 139 i;ay be inflated so as to secure distal end 127 of delivery catheter 106 in position within coronary sinus 30, Next, push rod 109 is passed down the central lumen 136 of delivery catheter 106. As the push rod's straight, substantially rigid elongated body 157 is passed down central lumen 136 of delivery catheter i;
106, it will force the delivery catheter to assume a straight configuration at the point where the straight, substantial;Ly rigid elongated body 157 currently resides: As push rod 109 is pushed down delivery catheter 106; balloon,139 will hold the distal end of the delivery catheter in position within coronary sinus 30.
Push rod 109 is pushed down delivery catheter 106, utilizing removable proximal stiffener 160 as needed, until the straight, substantially rigid elongated body 157 is.:=located adjacent to the posterior annulus of mitral valve 36. See Fig. 7. As this occurs, the presence of the straight, substantially rigid elongated body 157 in delivery catheter 106 will cause at least a portion of coronary sinus 30 to assume a substantially straight configuration at this point, so that the posterior annulus of mitral valve 36 is forced anteriorly. This will cause the mitral valve's posterior leaflet 39 to also move anteriorly so as to improve mitral valve leaflet coaptation anc~ thereby reduce (or completely eliminate) mitral valve regurgitation. In this respect it should be appreciated that the posterior annulus may be shifted anteriorly so as to achieve, or to attempt to achieve to the extent anatomically possible, leaflet-to-leaflet engagement or leaflet-to-annulus engagement (e. g., where a leaflet may be tethered due to left ventricular distortion).
Both of these types o,. engagement, or targeted engagement, are intended to be encompassed by the terms "improved leaflet coaptation" andlor "increased leaflet coaptation" and the like. Using standard visualisation means (e.g. echocardiography or fluoroscopy), the exact position of the straight, substantially rigid elongated body 157 is adjusted so as to reduce (or completely eliminate) regurgitation in mitral valve 36.

In this respect it should be appreciated that the straight, substantially rigid elongated body 157 is preferably sized to be somewhat less than the length of the coronary sinus between coronary ostium 27 and AIV 32. However, in some circumstances it may be desirable to size the straight, substantially rigid elongated body 157 so that it will extend out of the coronary sinus and into the right atrium.
Furthermore, it should also be appreciated that the system provides a degree of tactile feedback to the user during deployment. More particularly, substantial resistance will typically be encountered as the straight, substantially rigid elongated body 157 is pushed out of _ight atrium 24 and into coronary sinus 30; then resistance will typically drop as body 157 is moved through the coronary sinus; and then resistance will typic~~lly increase significantly again as the distal tip of body 157 comes to the far end 31 of the coronary sinus. Thus, there is a sort of tactile "sweet spot" when the straight, substantially rigid elongated body 157 is located in the coronary sinus between coronary ostium 27 and AIV 32, and this tactile "sweet spot" can be helpful to the user in positioning the straight, substantially rigid elongated body 157 in_coronary sinus 30.
At this point the straight, substantially rigid elongated body 157 is docked in position, e.g., by closing adjustable valve 133, and balloon 139 may be deflated.
System 100 is left in this position until it is no longer needed. In some cases this may mean that system 100 is left in position for a period of a few hours, days or weeks; in other cases system 100 may be substantially permanent. If and when system 100 is to be removed, push rod i09 is removed from delivery catheter 106, and then delivery catheter 106 is removed from the patient.
Thus it will be seen that with the present invention, the straight, substantially rigid elongated body 157 is essentially force-fit into the normally curved portion of the coronary sinus adjacent to the mitral valve's poster_~or leaflet. By properly sizing the length of the straight, substantially rigid elongated body 157 relative to the natural curvature of the patient's anatomy, and by properly positioning the straight, substantially rigid elongated body 157 in the patient's coronary sinus, the straight, substantially rigid elongated body will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of t.:he mitral valve. This action will in turn drive the posterior annulus of the mitral valve anteriorly, so as to improve leaflet coaptation and thereby reduce mitral regurgitation. Thus, by inserting the straight, substantially rigid elongated body 157 into the coronary sinus adjacent to the posterior leaflet of the mural valve, the annulus of the mitral valve is effectively manipulated so that it will assume an increa~~ed radius of curvature.
It has also been.found that by inserting the straight, substantially rigid elongated body into the coronary sinus adjacent to the posterior leaflet of the mural valve, the left ventricle may also be remodeled so as to help alleviate congestive heart failure.
It is significant to note that with the present invention, the distal~and proximal ends of straight, substantially rigid elongated body 157 apply a posteriorly-directed .force on the walls of coronary sinus 30 (e.g., as shown with arrows P in Fig. 7) while the intermediate portion of straight, substantially rigid elongated body 157 applies an anteriorly-directed force on the walls of coronary sinus 30 (e.g., as shown with arrows A in Fig. 7).
In some cases the proximal end 130 of delivery catheter 106 may be fixed to the patient's outer skin using standard patient care methods such as adhesive tape, pursestring sutures, skin staples, etc. In other cases proximal end 130 of delivery catheter 106 may include a sewing cuff whereby the delivery catheter may be secured to the patient's tissue by suturing. See, for example, Fig. 8, where a sewing cuff 166 is shown attached to the proximal end 130 of delivery catheter 106. If desired, an element 169 may be provided proximal to adjustable valve 133, whereby flexible push rod 109. may be made fast to delivery catheter 106. By way.of example, element 169 may comprise a crimpable element to secure flexible push rod 109 to delivery catheter 106, which is in turn secured to the patient. If desired, the proximal end of the assembly may be embedded under the skin of the patient, e.g., in the case of a permanent implant.
As noted above, it can be helpful to anchor the distal end of deliver; catheter 106 in position within the coronary sinus pr_or to pushing push rod 109 into the delivery catheter. Such an arrangement will keep the delivery catheter in place as the push rod makes the turn within the right atrium and enters the coronary sinus. In the absence of such anchoring, the push rod may drive the delivery catheter down the inferior vena~cava 21. By securing the distal end of delivery catheter 106 to the walls of coronary sinus 30, the delivery catheter can be stabilized against diversion down the inferior vena cava 21 when the straight, substantially rigid elongate body 157 encounters initial resistance to making the turn into the coronary sinus.
The balloon 139 is one way of accomplishing such anchoring. However, it is also possible to utilize other types of securing mechanisms to anchor the distal end 127 of delivery catheter 106 in position within coronary sinus 30, e.g., spring clips, ribs, etc.
Alternatively, and looking next at Fig. 9, the distal end 151 of push rod 109 may itself be provided with a distal anchor, e.g., such as the distal anchor 172 shown in Fig. 9.
It is also possible to prevent diversion of delivery catheter 106 down inferior vena cava 21 without anchoring the distal end of delivery catheter 106 or flexible push rod 109 to the walls of the coronary sinus. More particularly, and looking now at Fig. 9A, there is shown a support catheter 173 which ..
is formed out of a more rigid material than delivery catheter 106. Support catheter 173 is constructed so that its distal end 174 can be positioned in coronary ostium 27 and then its sidewall 174A can support delivery catheter 106 adjacent to inferior vena cava 21 when push rod 109 is passed down delivery catheter 106, whereby to prevent delivery catheter 106 from diverting down inferior vena cava 106. Fig. 9A also shows an introducer catheter 174B at the entrance to jugular vein 18.
As noted above, as push rod 109 is advanced to the region adjacent to the posterior annulus of the mitral valve, the straight, substantially rigid elongated body 157 will distort the natural configuration of the coronary sinus so that it will assume a substantially straight configuration. While this action induces the desired valve remodeling, it can also induce a significant stress on the walls of the coronary sinus, particularly at the distal and proximal ends of the straight, substantially rigid elongated body 157, where stress will be concentrated.
To this end, the construction of the straight, substantially rigid elongated body 157 may be modified somewhat so as to better distribute this stress. More particularly, and looking next at Fig. 10, the distal and proximal ends of straight, substantially rigid elongated body 157 may include relatively flexible portions 175 to help ~.~etter distribute the stress exerted on the walls of the coronary sinus.
Additionally, and/or alternatively, any taper applied to the distal and proximal ends of straight, substantially rigid elongated body 157 may be elongated, e.g., such as shown at 178 in Fig. 11, so as to better distribute the stress imposed on the walls of the coronary sinus.
Looking next at Fig. i~, there is shown a system 181 which comprises another preferred embodiment of the present invention. More particularly, system 181 generally comprises the guidewire 103, a straight, substantially rigid elongated body 184 and a push cannula 187.
Guidewire 103 is as previously described.
Straight, substantially rigid elongated body 184, which may have a variety of different lengths, comprises a distal enc-~ 188 and a proximal end 190, A

central lumen 193 extends between distal end 188 and proximal end 190. Central lumen 193 accommodates guidewire 103.
Push cannula 187 comprises a distal end 194 and a proximal end 196. A central lumen 199 extends between distal end 194 and proximal end 196. Central lumen 199 accommodates guidewire 103.
System 181 may be used as follows to reduce mitral regurgitation.
First, distal end 115 of guidewire 103 is passed down jugular vein 18 for the left subclavian vein 15) of a patient, down suZ~erior vena cava 9, through right atrium 24 of the heart, and into coronary sinus 30.
It will be appreciated that as flexible guidewire 103 is passed down coronary sinus 30, the guidewire will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the guidewire. The guidewire's atraumatic spring tip 121 will help minimize darlage to vascular structures as the guidewire is advanced into position.

Next, distal end 188 of straight, substantially rigid elongated body 184 is placed over proximal end 118 of guidewire 103 and passed a short distance down the guidewire. Then the distal end 194 of push cannula 187 is placed over proximal end 118 of guidewire 103, and then push cannula 187 is advanced down the guidewire. As push cannula 187 is advanced down the guidewire, its distal end 194 pushes the straight, substantially rigid elongated body 184 ahead of it. See Fig. 13.
As the straight, substantially rigid elongated body 184 is passed down the coronary sinus, it will force the coronary sinus to assume a straight configuration at the ~?oint where the straight, substantially rigid elongated body 184 currently resides. Push cannula 187 is pushed down guidewire as needed, until the straight, substantially rigid elongated body 184 is located adjacent to the posterior annulus of the mitral valve. As this occurs, the presence of the straight, substantially rigid elongated body 184 in the coronary sinus will cause coronary sinus to assume a substantially straight configuratio7;i at this point, so that the posterior annulus of :she mitral valve is forced anteriorly. This will cause the posterior mitral valve leaflet to also move anteriorly so as to improve leaflet coaptation and thereby reduce (or completely eliminate) mitral valve regurgitation. Using standard visualization means (e.g. echocardiography or fluoroscopy), the exact position of the straight, substantially rigid elongated body may be adjusted so as to reduce (or completely eliminate) regurgitation in the mitral valve.
If desired, the push cannula 187 may be provided with a releasably attachable interface (e.g., a grasper) so that it may releasably secure the proximal end 190 of the straight, substantially rigid elongated body 184. Such a feature will permit the straight, substantially rigid elongated body to be pulled backward within the cc ronary sinus, either for positioning or removal purposes.
',, Alternatively, elongated body 184 or 157 may have any of a variety of non-straight shapes along its length. For example, the elongated body may be wavy, spiraled, or curved along all or a portion of its length. By way of example, elongated body 157 and/or 184 may have a curved configuration so as to invert the natural curvature~of the coronary sinus, i.e., so that it is bowed towards the anterior annulus. Or the elongated body may have a compound shape along its length, e.g., it may have a sort of "w" shape, with the center of the "w" being directed towards the anterior annulus. Any of these or other alternate shapes may effect the anterior displacement of the posterior annulus that results in reduction of the mitral valve regurgitation.
In other alternative embodiments, the elongated body may be flexible along at least a portion of its length. Regional flexibility and regional stiffness may allow for straightening of select locations of the coronary sinus and corresponding locations of the posterior mitral annulus. This can cause regions of the mitral annulus to move anteriorly, thus causing regional improvements in leaflet coaptation. In addition, the elongated body may be formed by two end segments connected together by a filament: by anchoring the two~end'segments relative to the anatomy and pulling the filament taught, the naturally curved wall of the coronary sinus can be straightened, whereby to move the posterior mitral annulus anteriorly and thereby reduce mitral regurgitation.
It is to be understood that the present invention is by no means limited to the particular constructions herein disclosed and/or shown in the drawings, but also comprises any modifications or equivalents within the scope of the claims.

Claims (35)

What Is Claimed Is:
1. A method for reducing mitral regurgitation comprising:
inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to straighten the natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
2. A method for reducing mitral regurgitation comprising:
inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to move at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve anteriorly, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
3. A method for reducing mitral regurgitation comprising:
inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to reduce the degree of natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
4. A method for reducing mitral regurgitation comprising:
inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral value, the apparatus being adapted to increase the natural radius of curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
5. A method for reducing mitral regurgitation comprising:
inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the;apparatus having a distal end, a proximal end and an intermediate portion, the apparatus being configured so that when the apparatus is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends will apply a posteriorly-directed force to the walls of the coronary sinus and the intermediate portion will apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
6. A method for reducing mitral regurgitation comprising:
inserting a substantially straight elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially straight elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus and thereby improve leaflet coaptation.
7. A method for reducing mural regurgitation comprising:
inserting a substantially rigid elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the substantially rigid elongated body being configured relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a different configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus.anteriorly and thereby improve leaflet coaptation.
8. A method for reducing mitral regurgitation comprising:
inserting a straight, substantially rigid elongated body into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mural valve so that when the straight, substantially rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mural valve, whereby to increase the radius of curvature of the mitral annulus and thereby improve leaflet coaptation.
9. A method according to claim 8 wherein the straight, substantially rigid elongated body is inserted into the coronary sinus percutaneously.
10. A method according to claim 9 wherein the straight, substantially rigid elongated body is inserted into the coronary sinus by introducing the straight, substantially rigid elongated body into the patient's jugular vein, passing it down the superior vena cava, passing it through the right atrium and then passing it into the coronary sinus.
11. A method according to claim 9 wherein the straight, substantially rigid elongated body is inserted into the coronary sinus by introducing the straight, substantially rigid elongated body into the patient's left subclavian vein, passing it down the superior vena cava, passing it through the right atrium and then passing it into the coronary sinus.
12. A method according to claim 8 wherein the straight, substantially rigid elongated body is inserted into the coronary sinus through an incision in the patient's hear.
13. A method according to claim 8 wherein the straight, substantially rigid elongated body is guided into position by passing it through a pre-positioned delivery catheter.
14. A method according to claim 13 wherein the straight, substantially rigid elongated body is guided into position by inserting a guidewire into the coronary sinus, passing the delivery catheter over the guidewire and into the coronary sinus, removing the guidewire, and then passing the straight, substantially rigid elongated body down the delivery catheter.
15. A method according to claim 8 wherein the straight, substantially rigid elongated body is guided into position by passing it over a pre-positioned guidewire.
16. A method according to claim 15 wherein the straight, substantially rigid elongated body is guided into position by inserting a guidewire into the coronary sinus and then passing the straight, substantially rigid elongated body down the guidewire.
17. A method according to claim 8 further comprising the subsequent step of removing the straight, substantially rigid elongated body from the coronary sinus.
18. A method according to claim 8 wherein the straight, substantially rigid elongated body is inserted under visualization.
19. A method according to claim 18 wherein visualization is achieved by using a procedure chosen from the group consisting of fluoroscopy, echocardiography, intravascular ultrasound, angioscopy and real-time magnetic resonance imaging.
20. A method according to claim 8 including the additional step of assessing the efficacy of the procedure.
21. Apparatus for reducing mitral regurgitation comprising:
a body having a distal end, a proximal end and an intermediate portion, the body being configured so that when the body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends will apply a posteriorly-directed :force to the walls of the coronary sinus, and the intermediate portion will apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus of the mitral valve anteriorly and thereby improve leaflet coaptation.
22. Apparatus for reducing mitral regurgitation comprising:
a substantially straight elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially straight elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially straight elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus, moving it anteriorly, and thereby improve leaflet coaptation.
23. Apparatus for reducing mitral regurgitation comprising:
a substantially rigid elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the substantially rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a different configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
24. Apparatus for reducing mural regurgitation comprising:
a straight, substantially rigid elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the length of the straight, substantially rigid elongated body being sized relative to the natural curvature of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve so that when the straight, substantially rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to increase the radius of curvature of the mitral annulus, moving it anteriorly, and thereby improve leaflet coaptation.
25. Apparatus according to claim 24 further comprising a delivery catheter adapted to be positioned within the coronary sinus of the patient, said flexible deliver-catheter being formed out of a flexible material, so that it will substantially assume the configuration of the coronary sinus, said delivery catheter being adapted to receive said straight, substantially rigid elongated body therein.
26. Apparatus according to claim 25 wherein said straight, substantially rigid elongated body is mounted to a rod, wherein said rod is formed out of a flexible material so that said rod will assume the configuration of the coronary sinus, and further wherein said rod is sized to fit within said delivery catheter.
27. Apparatus according to claim 24 further comprising a removable guidewire for positioning said delivery catheter in the coronary sinus.
28. Apparatus according to claim 24 further comprising a guidewire adapted to be positioned within the coronary sinus, said guidewire being formed out of a flexible material so that it will substantially assume the configuration of the coronary sinus, and further wherein the straight, substantially rigid elongated body is cannulated for riding along said guidewire.
29. Apparatus according to claim 24 wherein at least one of the distal and proximal ends of said straight, substantially rigid elongated body includes a flexible portion for relieving the stress imposed on the coronary sinus when said straight, substantially rigid elongated body is disposed within the coronary sinus.
30. Apparatus according to claim 24 wherein at least one of the distal and proximal ends of said straight, substantially rigid elongated body is tapered for relieving,the stress imposed on the coronary sinus when said straight, substantially rigid elongated body is disposed within the coronary sinus.
31. Apparatus according to claim 24 wherein said straight, substantially rigid elongated body has a length no longer than the segment of the coronary sinus located between the coronary ostium and the AIV.
32. Apparatus according to claim 25 wherein said apparatus further comprises a support catheter for preventing said delivery catheter from diverting into the inferior vena cava when said straight, substantially rigid elongated body is passed through said delivery catheter.
33. A method for reducing mitral regurgitation comprising:
inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to invert the natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
34. Apparatus for reducing mitral regurgitation comprising:
an elongated body adapted to be inserted into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus being adapted to invert the natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
35. A method according to claim 8 wherein said straight, substantially rigid elongated body is guided into position without the use of a guide catheter and a guidewire.
CA002437387A 2001-02-05 2002-02-05 Method and apparatus for improving mitral valve function Abandoned CA2437387A1 (en)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US26676601P 2001-02-05 2001-02-05
US60/266,766 2001-02-05
US27389301P 2001-03-05 2001-03-05
US60/273,893 2001-03-05
US27815301P 2001-03-23 2001-03-23
US60/278,153 2001-03-23
US27997401P 2001-03-29 2001-03-29
US27997301P 2001-03-29 2001-03-29
US60/279,973 2001-03-29
US60/279,974 2001-03-29
US28003801P 2001-03-30 2001-03-30
US60/280,038 2001-03-30
US28382001P 2001-04-13 2001-04-13
US60/283,820 2001-04-13
US31221701P 2001-08-14 2001-08-14
US60/312,217 2001-08-14
US33948101P 2001-10-26 2001-10-26
US60/339,481 2001-10-26
US34842402P 2002-01-14 2002-01-14
US60/348,424 2002-01-14
PCT/US2002/003550 WO2002062408A2 (en) 2001-02-05 2002-02-05 Method and apparatus for improving mitral valve function

Publications (1)

Publication Number Publication Date
CA2437387A1 true CA2437387A1 (en) 2002-08-15

Family

ID=27581208

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002437387A Abandoned CA2437387A1 (en) 2001-02-05 2002-02-05 Method and apparatus for improving mitral valve function

Country Status (7)

Country Link
US (2) US6656221B2 (en)
EP (1) EP1367962A4 (en)
JP (1) JP4184794B2 (en)
CN (1) CN100342829C (en)
AU (1) AU2002240288B2 (en)
CA (1) CA2437387A1 (en)
WO (1) WO2002062408A2 (en)

Families Citing this family (219)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100566463B1 (en) 1995-01-31 2006-03-31 가부시끼가이샤 히다치 세이사꾸쇼 Semiconductor memory device
US6406420B1 (en) * 1997-01-02 2002-06-18 Myocor, Inc. Methods and devices for improving cardiac function in hearts
US6050936A (en) 1997-01-02 2000-04-18 Myocor, Inc. Heart wall tension reduction apparatus
US7883539B2 (en) 1997-01-02 2011-02-08 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
ATE445366T1 (en) 1997-06-27 2009-10-15 Univ Columbia DEVICE FOR REPAIRING CIRCUIT VALVES
FR2768324B1 (en) 1997-09-12 1999-12-10 Jacques Seguin SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER
US6332893B1 (en) 1997-12-17 2001-12-25 Myocor, Inc. Valve to myocardium tension members device and method
US6260552B1 (en) 1998-07-29 2001-07-17 Myocor, Inc. Transventricular implant tools and devices
US20040044350A1 (en) 1999-04-09 2004-03-04 Evalve, Inc. Steerable access sheath and methods of use
US10327743B2 (en) 1999-04-09 2019-06-25 Evalve, Inc. Device and methods for endoscopic annuloplasty
ATE484241T1 (en) 1999-04-09 2010-10-15 Evalve Inc METHOD AND DEVICE FOR HEART VALVE REPAIR
US8216256B2 (en) 1999-04-09 2012-07-10 Evalve, Inc. Detachment mechanism for implantable fixation devices
US6752813B2 (en) 1999-04-09 2004-06-22 Evalve, Inc. Methods and devices for capturing and fixing leaflets in valve repair
US7811296B2 (en) 1999-04-09 2010-10-12 Evalve, Inc. Fixation devices for variation in engagement of tissue
US7226467B2 (en) 1999-04-09 2007-06-05 Evalve, Inc. Fixation device delivery catheter, systems and methods of use
SE514718C2 (en) 1999-06-29 2001-04-09 Jan Otto Solem Apparatus for treating defective closure of the mitral valve apparatus
US7192442B2 (en) 1999-06-30 2007-03-20 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US6997951B2 (en) 1999-06-30 2006-02-14 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
EP1113497A3 (en) * 1999-12-29 2006-01-25 Texas Instruments Incorporated Semiconductor package with conductor impedance selected during assembly
US6989028B2 (en) * 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US6402781B1 (en) 2000-01-31 2002-06-11 Mitralife Percutaneous mitral annuloplasty and cardiac reinforcement
DE10045719B4 (en) 2000-09-15 2018-01-11 Inventa-Fischer Gmbh & Co. Kg Process for the preparation of polyesters with reduced content of acetaldehyde
WO2004030569A2 (en) * 2002-10-01 2004-04-15 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus
US20050222489A1 (en) 2003-10-01 2005-10-06 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of a bridge implant
US20060106279A1 (en) 2004-05-14 2006-05-18 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of a bridge implant having an adjustable bridge stop
US8956407B2 (en) * 2000-09-20 2015-02-17 Mvrx, Inc. Methods for reshaping a heart valve annulus using a tensioning implant
US20050228422A1 (en) * 2002-11-26 2005-10-13 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools
US8784482B2 (en) * 2000-09-20 2014-07-22 Mvrx, Inc. Method of reshaping a heart valve annulus using an intravascular device
US20060106278A1 (en) * 2004-05-14 2006-05-18 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of an adjustable bridge implant system
WO2004030568A2 (en) * 2002-10-01 2004-04-15 Ample Medical, Inc. Device and method for repairing a native heart valve leaflet
US20090287179A1 (en) * 2003-10-01 2009-11-19 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools
US20080091264A1 (en) 2002-11-26 2008-04-17 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools
WO2004030570A2 (en) * 2002-10-01 2004-04-15 Ample Medical, Inc. Devices for retaining native heart valve leaflet
US6723038B1 (en) 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
US6602286B1 (en) 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US6810882B2 (en) * 2001-01-30 2004-11-02 Ev3 Santa Rosa, Inc. Transluminal mitral annuloplasty
EP1363559A4 (en) 2001-02-05 2008-10-01 Viacor Inc Apparatus and method for reducing mitral regurgitation
US6656221B2 (en) * 2001-02-05 2003-12-02 Viacor, Inc. Method and apparatus for improving mitral valve function
WO2002096275A2 (en) * 2001-03-05 2002-12-05 Viacor, Incorporated Apparatus and method for reducing mitral regurgitation
US6890353B2 (en) * 2001-03-23 2005-05-10 Viacor, Inc. Method and apparatus for reducing mitral regurgitation
US7186264B2 (en) * 2001-03-29 2007-03-06 Viacor, Inc. Method and apparatus for improving mitral valve function
US7037334B1 (en) 2001-04-24 2006-05-02 Mitralign, Inc. Method and apparatus for catheter-based annuloplasty using local plications
US8202315B2 (en) 2001-04-24 2012-06-19 Mitralign, Inc. Catheter-based annuloplasty using ventricularly positioned catheter
US20060069429A1 (en) * 2001-04-24 2006-03-30 Spence Paul A Tissue fastening systems and methods utilizing magnetic guidance
US6676702B2 (en) 2001-05-14 2004-01-13 Cardiac Dimensions, Inc. Mitral valve therapy assembly and method
US6800090B2 (en) 2001-05-14 2004-10-05 Cardiac Dimensions, Inc. Mitral valve therapy device, system and method
US20030078654A1 (en) * 2001-08-14 2003-04-24 Taylor Daniel C. Method and apparatus for improving mitral valve function
AU2002362442B2 (en) * 2001-10-01 2008-08-07 Ample Medical, Inc. Methods and devices for heart valve treatments
US7144363B2 (en) * 2001-10-16 2006-12-05 Extensia Medical, Inc. Systems for heart treatment
US6942672B2 (en) * 2001-10-23 2005-09-13 Vascor, Inc. Method and apparatus for attaching a conduit to the heart or a blood vessel
US7052487B2 (en) 2001-10-26 2006-05-30 Cohn William E Method and apparatus for reducing mitral regurgitation
US7311729B2 (en) * 2002-01-30 2007-12-25 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US6949122B2 (en) 2001-11-01 2005-09-27 Cardiac Dimensions, Inc. Focused compression mitral valve device and method
US6824562B2 (en) 2002-05-08 2004-11-30 Cardiac Dimensions, Inc. Body lumen device anchor, device and assembly
US7635387B2 (en) 2001-11-01 2009-12-22 Cardiac Dimensions, Inc. Adjustable height focal tissue deflector
US6575971B2 (en) 2001-11-15 2003-06-10 Quantum Cor, Inc. Cardiac valve leaflet stapler device and methods thereof
US6908478B2 (en) * 2001-12-05 2005-06-21 Cardiac Dimensions, Inc. Anchor and pull mitral valve device and method
US6793673B2 (en) 2002-12-26 2004-09-21 Cardiac Dimensions, Inc. System and method to effect mitral valve annulus of a heart
US6976995B2 (en) 2002-01-30 2005-12-20 Cardiac Dimensions, Inc. Fixed length anchor and pull mitral valve device and method
US7179282B2 (en) 2001-12-05 2007-02-20 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
SE524709C2 (en) 2002-01-11 2004-09-21 Edwards Lifesciences Ag Device for delayed reshaping of a heart vessel and a heart valve
WO2003055417A1 (en) * 2001-12-28 2003-07-10 Edwards Lifesciences Ag Delayed memory device
US6764510B2 (en) 2002-01-09 2004-07-20 Myocor, Inc. Devices and methods for heart valve treatment
WO2003105670A2 (en) 2002-01-10 2003-12-24 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US6960229B2 (en) * 2002-01-30 2005-11-01 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US7125420B2 (en) * 2002-02-05 2006-10-24 Viacor, Inc. Method and apparatus for improving mitral valve function
US7048754B2 (en) 2002-03-01 2006-05-23 Evalve, Inc. Suture fasteners and methods of use
US7004958B2 (en) 2002-03-06 2006-02-28 Cardiac Dimensions, Inc. Transvenous staples, assembly and method for mitral valve repair
US6797001B2 (en) 2002-03-11 2004-09-28 Cardiac Dimensions, Inc. Device, assembly and method for mitral valve repair
US6752828B2 (en) 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
CA2877641C (en) 2002-05-08 2017-01-17 Cardiac Dimensions Pty. Ltd. Device and method for modifying the shape of a body organ
US8641727B2 (en) 2002-06-13 2014-02-04 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20050107811A1 (en) 2002-06-13 2005-05-19 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US9949829B2 (en) 2002-06-13 2018-04-24 Ancora Heart, Inc. Delivery devices and methods for heart valve repair
US7087064B1 (en) 2002-10-15 2006-08-08 Advanced Cardiovascular Systems, Inc. Apparatuses and methods for heart valve repair
US20050119735A1 (en) 2002-10-21 2005-06-02 Spence Paul A. Tissue fastening systems and methods utilizing magnetic guidance
CN1705462A (en) 2002-10-21 2005-12-07 米特拉利根公司 Method and apparatus for performing catheter-based annuloplasty using local plications
US7112219B2 (en) 2002-11-12 2006-09-26 Myocor, Inc. Devices and methods for heart valve treatment
US8187324B2 (en) 2002-11-15 2012-05-29 Advanced Cardiovascular Systems, Inc. Telescoping apparatus for delivering and adjusting a medical device in a vessel
US9149602B2 (en) 2005-04-22 2015-10-06 Advanced Cardiovascular Systems, Inc. Dual needle delivery system
US7335213B1 (en) 2002-11-15 2008-02-26 Abbott Cardiovascular Systems Inc. Apparatus and methods for heart valve repair
US20040098116A1 (en) 2002-11-15 2004-05-20 Callas Peter L. Valve annulus constriction apparatus and method
US7981152B1 (en) 2004-12-10 2011-07-19 Advanced Cardiovascular Systems, Inc. Vascular delivery system for accessing and delivering devices into coronary sinus and other vascular sites
US7404824B1 (en) 2002-11-15 2008-07-29 Advanced Cardiovascular Systems, Inc. Valve aptation assist device
US7485143B2 (en) 2002-11-15 2009-02-03 Abbott Cardiovascular Systems Inc. Apparatuses and methods for heart valve repair
US7316708B2 (en) 2002-12-05 2008-01-08 Cardiac Dimensions, Inc. Medical device delivery system
US7837729B2 (en) 2002-12-05 2010-11-23 Cardiac Dimensions, Inc. Percutaneous mitral valve annuloplasty delivery system
US6945957B2 (en) * 2002-12-30 2005-09-20 Scimed Life Systems, Inc. Valve treatment catheter and methods
US7314485B2 (en) 2003-02-03 2008-01-01 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20040186566A1 (en) * 2003-03-18 2004-09-23 Hindrichs Paul J. Body tissue remodeling methods and apparatus
US20040220654A1 (en) 2003-05-02 2004-11-04 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US10667823B2 (en) 2003-05-19 2020-06-02 Evalve, Inc. Fixation devices, systems and methods for engaging tissue
US7887582B2 (en) 2003-06-05 2011-02-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US7351259B2 (en) 2003-06-05 2008-04-01 Cardiac Dimensions, Inc. Device, system and method to affect the mitral valve annulus of a heart
WO2005018507A2 (en) 2003-07-18 2005-03-03 Ev3 Santa Rosa, Inc. Remotely activated mitral annuloplasty system and methods
AU2004258950B2 (en) * 2003-07-23 2010-11-04 Viacor, Inc. Method and apparatus for improving mitral valve function
US7998112B2 (en) 2003-09-30 2011-08-16 Abbott Cardiovascular Systems Inc. Deflectable catheter assembly and method of making same
US7004176B2 (en) 2003-10-17 2006-02-28 Edwards Lifesciences Ag Heart valve leaflet locator
WO2005046530A1 (en) * 2003-11-12 2005-05-26 Medtronic Vascular, Inc. Coronary sinus approach for repair of mitral valve reguritation
US7056286B2 (en) 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
CA2548541A1 (en) 2003-12-16 2005-06-30 Edwards Lifesciences Ag Device for changing the shape of the mitral annulus
US7837728B2 (en) 2003-12-19 2010-11-23 Cardiac Dimensions, Inc. Reduced length tissue shaping device
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US9526616B2 (en) 2003-12-19 2016-12-27 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US7794496B2 (en) 2003-12-19 2010-09-14 Cardiac Dimensions, Inc. Tissue shaping device with integral connector and crimp
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US7431726B2 (en) * 2003-12-23 2008-10-07 Mitralign, Inc. Tissue fastening systems and methods utilizing magnetic guidance
US8864822B2 (en) 2003-12-23 2014-10-21 Mitralign, Inc. Devices and methods for introducing elements into tissue
US20050159810A1 (en) * 2004-01-15 2005-07-21 Farzan Filsoufi Devices and methods for repairing cardiac valves
US7993397B2 (en) 2004-04-05 2011-08-09 Edwards Lifesciences Ag Remotely adjustable coronary sinus implant
CA2566666C (en) 2004-05-14 2014-05-13 Evalve, Inc. Locking mechanisms for fixation devices and methods of engaging tissue
US7713298B2 (en) * 2004-06-29 2010-05-11 Micardia Corporation Methods for treating cardiac valves with adjustable implants
US7566343B2 (en) 2004-09-02 2009-07-28 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
CA2580053C (en) 2004-09-14 2014-07-08 Edwards Lifesciences Ag. Device and method for treatment of heart valve regurgitation
JP5124274B2 (en) 2004-09-27 2013-01-23 エヴァルヴ インコーポレイテッド Method and apparatus for grasping and evaluating tissue
US8052592B2 (en) 2005-09-27 2011-11-08 Evalve, Inc. Methods and devices for tissue grasping and assessment
US20090043381A1 (en) * 2004-10-05 2009-02-12 Macoviak John A Atrioventricular valve annulus repair systems and methods including retro-chordal anchors
CN101443073B (en) * 2004-11-24 2011-08-03 维亚科公司 Method and apparatus for improving mitral valve function
US7211110B2 (en) 2004-12-09 2007-05-01 Edwards Lifesciences Corporation Diagnostic kit to assist with heart valve annulus adjustment
AU2006206254B2 (en) 2005-01-20 2012-02-09 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US20060173490A1 (en) 2005-02-01 2006-08-03 Boston Scientific Scimed, Inc. Filter system and method
US7854755B2 (en) 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US7878966B2 (en) 2005-02-04 2011-02-01 Boston Scientific Scimed, Inc. Ventricular assist and support device
US8470028B2 (en) 2005-02-07 2013-06-25 Evalve, Inc. Methods, systems and devices for cardiac valve repair
US7780722B2 (en) 2005-02-07 2010-08-24 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7670368B2 (en) 2005-02-07 2010-03-02 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
EP3967269A3 (en) 2005-02-07 2022-07-13 Evalve, Inc. Systems and devices for cardiac valve repair
US7867274B2 (en) 2005-02-23 2011-01-11 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US10219902B2 (en) 2005-03-25 2019-03-05 Mvrx, Inc. Devices, systems, and methods for reshaping a heart valve anulus, including the use of a bridge implant having an adjustable bridge stop
US7722666B2 (en) 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7357815B2 (en) * 2005-04-21 2008-04-15 Micardia Corporation Dynamically adjustable implants and methods for reshaping tissue
US7500989B2 (en) * 2005-06-03 2009-03-10 Edwards Lifesciences Corp. Devices and methods for percutaneous repair of the mitral valve via the coronary sinus
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
US8951285B2 (en) 2005-07-05 2015-02-10 Mitralign, Inc. Tissue anchor, anchoring system and methods of using the same
US20080221673A1 (en) * 2005-08-12 2008-09-11 Donald Bobo Medical implant with reinforcement mechanism
EP1919400A1 (en) * 2005-08-12 2008-05-14 Edwards Lifesciences Corporation Medical implant with reinforcement mechanism
US9492277B2 (en) 2005-08-30 2016-11-15 Mayo Foundation For Medical Education And Research Soft body tissue remodeling methods and apparatus
US7569071B2 (en) 2005-09-21 2009-08-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US20070073391A1 (en) * 2005-09-28 2007-03-29 Henry Bourang System and method for delivering a mitral valve repair device
US20070173926A1 (en) * 2005-12-09 2007-07-26 Bobo Donald E Jr Anchoring system for medical implant
US7799038B2 (en) 2006-01-20 2010-09-21 Boston Scientific Scimed, Inc. Translumenal apparatus, system, and method
US7637946B2 (en) 2006-02-09 2009-12-29 Edwards Lifesciences Corporation Coiled implant for mitral valve repair
US7503932B2 (en) 2006-04-11 2009-03-17 Cardiac Dimensions, Inc. Mitral valve annuloplasty device with vena cava anchor
US8463709B2 (en) * 2006-04-11 2013-06-11 Dell Products L.P. Identifying and labeling licensed content in an embedded partition
WO2007136532A2 (en) * 2006-05-03 2007-11-29 St. Jude Medical, Inc. Soft body tissue remodeling methods and apparatus
US11285005B2 (en) 2006-07-17 2022-03-29 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US20080065205A1 (en) * 2006-09-11 2008-03-13 Duy Nguyen Retrievable implant and method for treatment of mitral regurgitation
US8388680B2 (en) 2006-10-18 2013-03-05 Guided Delivery Systems, Inc. Methods and devices for catheter advancement and delivery of substances therethrough
US20110257723A1 (en) 2006-11-07 2011-10-20 Dc Devices, Inc. Devices and methods for coronary sinus pressure relief
US10624621B2 (en) 2006-11-07 2020-04-21 Corvia Medical, Inc. Devices and methods for the treatment of heart failure
US9232997B2 (en) 2006-11-07 2016-01-12 Corvia Medical, Inc. Devices and methods for retrievable intra-atrial implants
US10413284B2 (en) 2006-11-07 2019-09-17 Corvia Medical, Inc. Atrial pressure regulation with control, sensing, monitoring and therapy delivery
WO2008091493A1 (en) 2007-01-08 2008-07-31 California Institute Of Technology In-situ formation of a valve
WO2008097589A1 (en) 2007-02-05 2008-08-14 Boston Scientific Limited Percutaneous valve, system, and method
US8911461B2 (en) 2007-03-13 2014-12-16 Mitralign, Inc. Suture cutter and method of cutting suture
US11660190B2 (en) 2007-03-13 2023-05-30 Edwards Lifesciences Corporation Tissue anchors, systems and methods, and devices
US8845723B2 (en) 2007-03-13 2014-09-30 Mitralign, Inc. Systems and methods for introducing elements into tissue
US20080255447A1 (en) * 2007-04-16 2008-10-16 Henry Bourang Diagnostic catheter
US8828079B2 (en) 2007-07-26 2014-09-09 Boston Scientific Scimed, Inc. Circulatory valve, system and method
US8100820B2 (en) 2007-08-22 2012-01-24 Edwards Lifesciences Corporation Implantable device for treatment of ventricular dilation
WO2009052438A2 (en) * 2007-10-19 2009-04-23 Guided Delivery Systems Inc. Devices for termination of tethers
US9125632B2 (en) * 2007-10-19 2015-09-08 Guided Delivery Systems, Inc. Systems and methods for cardiac remodeling
US7892276B2 (en) 2007-12-21 2011-02-22 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US20090222081A1 (en) * 2008-01-24 2009-09-03 Coherex Medical, Inc. Methods and apparatus for reducing valve prolapse
AU2009212393B2 (en) 2008-02-06 2014-07-24 Ancora Heart, Inc. Multi-window guide tunnel
CA2723810C (en) 2008-05-07 2015-06-30 Guided Delivery Systems, Inc. Deflectable guide
WO2009157818A1 (en) * 2008-06-27 2009-12-30 St. Jude Medical Ab A set comprising a medical implantable lead as well as a method for implanting the same
US8006594B2 (en) 2008-08-11 2011-08-30 Cardiac Dimensions, Inc. Catheter cutting tool
US20100121349A1 (en) * 2008-10-10 2010-05-13 Meier Stephen C Termination devices and related methods
AU2009302181B2 (en) * 2008-10-10 2015-08-06 Ancora Heart, Inc. Tether tensioning devices and related methods
US20100198192A1 (en) 2009-01-20 2010-08-05 Eugene Serina Anchor deployment devices and related methods
US9757107B2 (en) 2009-09-04 2017-09-12 Corvia Medical, Inc. Methods and devices for intra-atrial shunts having adjustable sizes
EP2477555B1 (en) 2009-09-15 2013-12-25 Evalve, Inc. Device for cardiac valve repair
EP2496189A4 (en) 2009-11-04 2016-05-11 Nitinol Devices And Components Inc Alternating circumferential bridge stent design and methods for use thereof
JP5730909B2 (en) 2010-01-29 2015-06-10 ディーシー ディヴァイシーズ インコーポレイテッド Device and system for treating heart failure
AU2011210741B2 (en) 2010-01-29 2013-08-15 Corvia Medical, Inc. Devices and methods for reducing venous pressure
US9107749B2 (en) 2010-02-03 2015-08-18 Edwards Lifesciences Corporation Methods for treating a heart
WO2012031204A2 (en) 2010-09-03 2012-03-08 Guided Delivery Systems Inc. Devices and methods for anchoring tissue
EP2624791B1 (en) 2010-10-08 2017-06-21 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design
CN103635226B (en) 2011-02-10 2017-06-30 可维亚媒体公司 Device for setting up and keeping intra-atrial pressure power release aperture
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
US8945177B2 (en) 2011-09-13 2015-02-03 Abbott Cardiovascular Systems Inc. Gripper pusher mechanism for tissue apposition systems
EP2886084B1 (en) 2011-12-12 2018-02-14 David Alon Heart valve repair device
US10398555B2 (en) 2011-12-12 2019-09-03 Cardiac Implants Llc Magnetically coupled cinching of a loop installed in a valve annulus
WO2013096965A1 (en) 2011-12-22 2013-06-27 Dc Devices, Inc. Methods and devices for intra-atrial devices having selectable flow rates
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
CN105392449B (en) 2013-06-06 2017-09-05 戴维·阿隆 Heart valve repair and replacing
US10070857B2 (en) 2013-08-31 2018-09-11 Mitralign, Inc. Devices and methods for locating and implanting tissue anchors at mitral valve commissure
US10675450B2 (en) 2014-03-12 2020-06-09 Corvia Medical, Inc. Devices and methods for treating heart failure
US9572666B2 (en) 2014-03-17 2017-02-21 Evalve, Inc. Mitral valve fixation device removal devices and methods
US10390943B2 (en) 2014-03-17 2019-08-27 Evalve, Inc. Double orifice device for transcatheter mitral valve replacement
WO2016014821A1 (en) 2014-07-23 2016-01-28 Corvia Medical, Inc. Devices and methods for treating heart failure
US10188392B2 (en) 2014-12-19 2019-01-29 Abbott Cardiovascular Systems, Inc. Grasping for tissue repair
EP3265004B1 (en) 2015-03-05 2023-06-28 Ancora Heart, Inc. Devices of visualizing and determining depth of penetration in cardiac tissue
WO2016144391A1 (en) 2015-03-11 2016-09-15 Mvrx, Inc. Devices, systems, and methods for reshaping a heart valve annulus
US10524912B2 (en) 2015-04-02 2020-01-07 Abbott Cardiovascular Systems, Inc. Tissue fixation devices and methods
EP3294218B1 (en) 2015-05-12 2022-02-09 Ancora Heart, Inc. Device for releasing catheters from cardiac structures
US10376673B2 (en) 2015-06-19 2019-08-13 Evalve, Inc. Catheter guiding system and methods
US10238494B2 (en) 2015-06-29 2019-03-26 Evalve, Inc. Self-aligning radiopaque ring
US10667815B2 (en) 2015-07-21 2020-06-02 Evalve, Inc. Tissue grasping devices and related methods
US10413408B2 (en) 2015-08-06 2019-09-17 Evalve, Inc. Delivery catheter systems, methods, and devices
US10238495B2 (en) 2015-10-09 2019-03-26 Evalve, Inc. Delivery catheter handle and methods of use
EP3386440A4 (en) 2015-12-10 2019-11-13 MVRx, Inc. Devices, systems, and methods for reshaping a heart valve annulus
US10736632B2 (en) 2016-07-06 2020-08-11 Evalve, Inc. Methods and devices for valve clip excision
US11071564B2 (en) 2016-10-05 2021-07-27 Evalve, Inc. Cardiac valve cutting device
US10363138B2 (en) 2016-11-09 2019-07-30 Evalve, Inc. Devices for adjusting the curvature of cardiac valve structures
US10398553B2 (en) 2016-11-11 2019-09-03 Evalve, Inc. Opposing disk device for grasping cardiac valve tissue
US10426616B2 (en) 2016-11-17 2019-10-01 Evalve, Inc. Cardiac implant delivery system
CN110381850B (en) 2016-11-18 2023-06-30 复心公司 Myocardial implant load sharing apparatus and method for promoting LV function
US10779837B2 (en) 2016-12-08 2020-09-22 Evalve, Inc. Adjustable arm device for grasping tissues
US10314586B2 (en) 2016-12-13 2019-06-11 Evalve, Inc. Rotatable device and method for fixing tricuspid valve tissue
US10390953B2 (en) 2017-03-08 2019-08-27 Cardiac Dimensions Pty. Ltd. Methods and devices for reducing paravalvular leakage
US11065119B2 (en) 2017-05-12 2021-07-20 Evalve, Inc. Long arm valve repair clip
WO2019028264A1 (en) 2017-08-03 2019-02-07 The Regents Of The University Of California Atrial cage for placement, securing and anchoring of atrioventricular valves
US11026791B2 (en) 2018-03-20 2021-06-08 Medtronic Vascular, Inc. Flexible canopy valve repair systems and methods of use
US11285003B2 (en) 2018-03-20 2022-03-29 Medtronic Vascular, Inc. Prolapse prevention device and methods of use thereof
EP3998969A4 (en) 2019-07-15 2023-08-02 Ancora Heart, Inc. Devices and methods for tether cutting
IT202000012562A1 (en) 2020-05-27 2021-11-27 Milano Politecnico DEVICE AND ASSEMBLY FOR REPAIRING A HEART VALVE
AU2021400419A1 (en) 2020-12-14 2023-06-29 Cardiac Dimensions Pty. Ltd. Modular pre-loaded medical implants and delivery systems

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4669473A (en) 1985-09-06 1987-06-02 Acufex Microsurgical, Inc. Surgical fastener
CA1303298C (en) * 1986-08-06 1992-06-16 Alain Carpentier Flexible cardiac valvular support prosthesis
US4944745A (en) * 1988-02-29 1990-07-31 Scimed Life Systems, Inc. Perfusion balloon catheter
US4917698A (en) 1988-12-22 1990-04-17 Baxter International Inc. Multi-segmented annuloplasty ring prosthesis
US5032113A (en) * 1989-04-13 1991-07-16 Scimed Life Systems, Inc. Innerless catheter
US5092889A (en) 1989-04-14 1992-03-03 Campbell Robert M Jr Expandable vertical prosthetic rib
US5269809A (en) 1990-07-02 1993-12-14 American Cyanamid Company Locking mechanism for use with a slotted suture anchor
CA2062000A1 (en) * 1991-03-07 1992-09-08 H. Robert Moorehead Site-selective reinforced catheter and methods of manufacturing and using the reinforced catheter
FR2683449A1 (en) * 1991-11-08 1993-05-14 Cardon Alain ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION.
US5509900A (en) * 1992-03-02 1996-04-23 Kirkman; Thomas R. Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US5332402A (en) * 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5443481A (en) * 1992-07-27 1995-08-22 Lee; Benjamin I. Methods and device for percutaneous sealing of arterial puncture sites
US5487730A (en) 1992-12-30 1996-01-30 Medtronic, Inc. Balloon catheter with balloon surface retention means
US6277107B1 (en) * 1993-08-13 2001-08-21 Daig Corporation Guiding introducer for introducing medical devices into the coronary sinus and process for using same
US5545209A (en) 1993-09-30 1996-08-13 Texas Petrodet, Inc. Controlled deployment of a medical device
US5640955A (en) * 1995-02-14 1997-06-24 Daig Corporation Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach
US5538509A (en) * 1994-01-31 1996-07-23 Richard-Allan Medical Industries, Inc. Trocar assembly
US5476506A (en) * 1994-02-08 1995-12-19 Ethicon, Inc. Bi-directional crimped graft
US6051020A (en) 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US6332896B1 (en) 1994-07-14 2001-12-25 Ortho Development Corporation Orthopaedic implant with proximal collar
CA2171896C (en) 1995-03-17 2007-05-15 Scott C. Anderson Multi-anchor stent
US5575799A (en) * 1995-03-30 1996-11-19 United States Surgical Corporation Articulating surgical apparatus
AU6260896A (en) * 1995-06-06 1996-12-24 Board Of Regents, The University Of Texas System Electrode system in iontophoretic treatment devices
US6132438A (en) * 1995-06-07 2000-10-17 Ep Technologies, Inc. Devices for installing stasis reducing means in body tissue
US6090136A (en) 1996-07-29 2000-07-18 Radiance Medical Systems, Inc. Self expandable tubular support
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US5755778A (en) * 1996-10-16 1998-05-26 Nitinol Medical Technologies, Inc. Anastomosis device
US5800495A (en) 1997-03-27 1998-09-01 Sulzer Intermedics Inc. Endocardial lead assembly
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6162245A (en) 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
CA2297914C (en) * 1997-07-22 2006-10-03 Baxter International Inc. Expandable annuloplasty ring
US6033436A (en) * 1998-02-17 2000-03-07 Md3, Inc. Expandable stent
US5980570A (en) 1998-03-27 1999-11-09 Sulzer Carbomedics Inc. System and method for implanting an expandable medical device into a body
US6241746B1 (en) 1998-06-29 2001-06-05 Cordis Corporation Vascular filter convertible to a stent and method
US6165194A (en) * 1998-07-24 2000-12-26 Micrus Corporation Intravascular flow modifier and reinforcement device
US6102945A (en) * 1998-10-16 2000-08-15 Sulzer Carbomedics, Inc. Separable annuloplasty ring
US6328765B1 (en) * 1998-12-03 2001-12-11 Gore Enterprise Holdings, Inc. Methods and articles for regenerating living tissue
US6086599A (en) * 1999-02-08 2000-07-11 The Regents Of The University Of California Micro devices using shape memory polymer patches for mated connections
US6258117B1 (en) * 1999-04-15 2001-07-10 Mayo Foundation For Medical Education And Research Multi-section stent
US6187040B1 (en) 1999-05-03 2001-02-13 John T. M. Wright Mitral and tricuspid annuloplasty rings
SE514718C2 (en) 1999-06-29 2001-04-09 Jan Otto Solem Apparatus for treating defective closure of the mitral valve apparatus
US7192442B2 (en) 1999-06-30 2007-03-20 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US6989028B2 (en) 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US6402781B1 (en) 2000-01-31 2002-06-11 Mitralife Percutaneous mitral annuloplasty and cardiac reinforcement
US6569198B1 (en) 2000-03-31 2003-05-27 Richard A. Wilson Mitral or tricuspid valve annuloplasty prosthetic device
US6585716B2 (en) * 2000-04-05 2003-07-01 Biocardia, Inc. Method of treating the heart
US6419696B1 (en) * 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US6602288B1 (en) * 2000-10-05 2003-08-05 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template, system and method of use
US7591826B2 (en) 2000-12-28 2009-09-22 Cardiac Dimensions, Inc. Device implantable in the coronary sinus to provide mitral valve therapy
JP4195612B2 (en) 2001-01-30 2008-12-10 エドワーズ ライフサイエンシーズ アーゲー Medical system and method for improving extracorporeal tissue structure
US6810882B2 (en) 2001-01-30 2004-11-02 Ev3 Santa Rosa, Inc. Transluminal mitral annuloplasty
US6656221B2 (en) * 2001-02-05 2003-12-02 Viacor, Inc. Method and apparatus for improving mitral valve function
US6800090B2 (en) 2001-05-14 2004-10-05 Cardiac Dimensions, Inc. Mitral valve therapy device, system and method
US6676702B2 (en) 2001-05-14 2004-01-13 Cardiac Dimensions, Inc. Mitral valve therapy assembly and method
US6949122B2 (en) 2001-11-01 2005-09-27 Cardiac Dimensions, Inc. Focused compression mitral valve device and method
US6805710B2 (en) * 2001-11-13 2004-10-19 Edwards Lifesciences Corporation Mitral valve annuloplasty ring for molding left ventricle geometry
US6908478B2 (en) 2001-12-05 2005-06-21 Cardiac Dimensions, Inc. Anchor and pull mitral valve device and method

Also Published As

Publication number Publication date
CN100342829C (en) 2007-10-17
EP1367962A2 (en) 2003-12-10
US20020183835A1 (en) 2002-12-05
JP4184794B2 (en) 2008-11-19
US6656221B2 (en) 2003-12-02
JP2004533862A (en) 2004-11-11
WO2002062408A3 (en) 2003-03-27
AU2002240288B2 (en) 2006-05-18
US20050049679A1 (en) 2005-03-03
WO2002062408A2 (en) 2002-08-15
EP1367962A4 (en) 2008-10-01
CN1582136A (en) 2005-02-16

Similar Documents

Publication Publication Date Title
AU2002240288B2 (en) Method and apparatus for improving mitral valve function
US7125420B2 (en) Method and apparatus for improving mitral valve function
AU2002240288A1 (en) Method and apparatus for improving mitral valve function
US7186264B2 (en) Method and apparatus for improving mitral valve function
US6790231B2 (en) Apparatus and method for reducing mitral regurgitation
US7052487B2 (en) Method and apparatus for reducing mitral regurgitation
EP1383448B1 (en) Apparatus for improving mitral valve function
US6890353B2 (en) Method and apparatus for reducing mitral regurgitation
US20030078654A1 (en) Method and apparatus for improving mitral valve function
AU2010200752A1 (en) Method and apparatus for improving mitral valve function
AU2006203499B2 (en) Method and apparatus for improving mitral valve function
WO2003034947A1 (en) Method and apparatus for reducing mitral regurgitation

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20120206